Renaissance Capital logo

GLUE News

US IPO Weekly Recap: Doximity pops more than 100% in a 16 IPO week

DOCS

16 IPOs went public in another active week for the IPO market, led by digital physicians network Doximity (DOCS), which soared 104% in its debut. The week’s IPOs were joined by four SPACs, as well as one postponement, Chinese social...read more

Preclinical oncology biotech Monte Rosa Therapeutics prices upsized IPO at $19 high end

Monte Rosa Therapeutics logo

Monte Rosa Therapeutics, a preclinical biotech developing small molecule protein degraders for cancer and other diseases, raised $222 million by offering 11.7 million shares at $19, the high end of the range of $17 to $19. The company offered 1.95 million more...read more

Preclinical oncology biotech Monte Rosa Therapeutics sets terms for $176 million IPO

Monte Rosa Therapeutics logo

Monte Rosa Therapeutics, a preclinical biotech developing small molecule protein degraders for cancer and other diseases, announced terms for its IPO on Monday. The Boston, MA-based company plans to raise $176 million by offering 9.8 million shares at a price...read more

US IPO Weekly Recap: June kicks off with a quiet 1 IPO week

DLO

Just one IPO entered public markets after the holiday weekend, but the pipeline remained active, with 14 IPOs and 10 SPACs submitting initial filings. Cross-border payment processor dLocal (DLO) priced well above the range to raise...read more